NYSE - Delayed Quote • USD
Emergent BioSolutions Inc. (EBS)
At close: 4:00 PM EDT
After hours: 7:00 PM EDT
All SEC Filings
Corporate Changes & Voting Matters
Periodic Financial Reports
Proxy Statements
Tender Offer/Acquisition Reports
Offering Registrations
-
-
-
-
Q1 2024 Emergent BioSolutions Inc Earnings Call
Q1 2024 Emergent BioSolutions Inc Earnings Call
Thomson Reuters StreetEvents • 26 days ago -
-
-
-
-
-
Narcan-Maker Emergent BioSolutions to Cut 300 Jobs, Close Facilities
Emergent BioSolutions is closing several manufacturing facilities and cutting hundreds of jobs as part of a restructuring as the company narrows its focus on products, including Narcan nasal spray.
The Wall Street Journal • 27 days ago -
-
-
-
-
-
-
-
-
-
Performance Overview
Trailing total returns as of 5/28/2024, which may include dividends or other distributions. Benchmark is S&P 500
Return | EBS | S&P 500 |
---|---|---|
YTD | +96.67% | +11.24% |
1-Year | -42.23% | +26.17% |
3-Year | -91.83% | +26.31% |